SILO

Silo Pharma, Inc. - Common Stock (SILO)

About Silo Pharma, Inc. - Common Stock (SILO)

Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Sarasota, FL.

Details

Daily high

$1.17

Daily low

$1.12

Price at open

$1.13

52 Week High

$4.50

52 Week Low

$0.77

Market cap

5.2M

Dividend yield

0.00%

Volume

35,741

Avg. volume

36,873

P/E ratio

-.97

Silo Pharma, Inc. - Common Stock News